Medical test and drug development technologies from UW Bioengineering have spun out into start-ups Nexgenia and Nanosurface Biomedical, with Coulter's help.
This May marks the 10th anniversary of the UW’s Coulter Translational Research Partnership in Biomedical Engineering, which has helped propel dozens of UW inventions from the lab toward clinical use. We profile one of Coulter’s recent successes: a platform for growing cardiac cells for drug toxicity testing. Researchers in BioE’s Deok-Ho Kim’s lab developed the technology, which was recently spun out to the start-up NanoSurface Biomedical.
Undergraduate student Krittika D’Silva, dual major in UW Bioengineering and Computer Science, builds apps for global health and to help those in developing regions.
UW Bioengineering alumnus Michael Kellen of Sage Bionetworks works to bring open-source software technology and culture to the medical research community.
What do at-home disease test kits, neuroscience and the fit of artificial limbs share in common the researchers’ dedication to serving the public good and improving health. We talk with three researchers about the motivations for their work and the impact it stands to make.
Mike Averkiou knows a thing or two about bringing worlds together. He’s lived half his [...]
New UW Bioengineering research assistant professor Gianluca Interlandi studies the molecular function of blood proteins involved in hemostasis and clotting.
Inside the Yager lab's at-home medical test kit is a two-dimensional paper network of switches [...]
In this issue: Chair's Letter - Note to Graduates - Features - News Briefs - [...]
UW Bioengineer Ruikang Wang’s non-invasive method for imaging vascular health holds promise for better diagnosis, monitoring and treatment of diseases.